Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE +0.36%, DAX +0.14%, CAC40 +0.46%

Jul 10 ,2025

  • Synopsis

    • European equity markets are set for a positive open amidst mostly higher Asian equities Thursday. Korea, Australia and Taiwan benchmarks outperforming while Greater China little changed and Japan weaker. S&P 500 futures easing afterhours.

    • In central banks, Austria central bank's Holzmann speech at 9:00CET at Forum on Digital Euro and Payments, the same time as ECB's Cipollone delivers lecture followed by a discussion at event organised by Bank of Slovenia. BOE's Breeden speech at 16:00BST at the Annual Chapman-Barrigan lecture series 'Weathering the storm: stability in a changing climate'. Bank of Frances Villeroy speaks in Paris. Russia central bank is expected to leave its benchmark interest rate unchanged at 5.75% whilst Serbia also announces its central bank interest rate decision.

    • Macro data due for release include Italy May industrial production, Denmark Jun CPI, Norway Jun CPI, Sweden May industrial production, Austria May industrial production, Greece May industrial production, Portugal Jun final CPI, Ireland Jun CPI, Netherlands May manufacturing production, Finland May industrial production, UK Jun house price balance - RICS

    • In earnings, DACHs region companies kicked off the session with Gerresheimer (GXI.GR) reporting Q2 EPS €0.90 vs FactSet €0.81and lowering FY organic revenue growth guidance, whilst Barry Callebaut (BARN.SW) reported 9M Sales CHF10.95B vs consensus CHF10.91B and lowered FY guidance and now expects mid to high single-digit increase in EBIT vs prior guidance a double-digit increase. Suedzucker (SZU.GR) released Q1 net income (€35M) vs FactSet €3.6M and Fielmann Group (FIE.GR) reported preliminary H1 adjusted EBITDA ~ €290M vs year-ago €230.0M and reaffirmed FY outlook. Elsewhere, Kemira (KEMIRA.FH) reported preliminary Q2 revenue €693.4M vs FactSet €719.6M.

    • Other companies due to report/release updates include Brunello Cucinelli (BC.IM), DCC (DCC.LN), Vistry Group (VTY.LN),

    • Analyst/Shareholder Events: WashTec (WSU.GR), Schaeffler (SHA0.GR) pre-close, Volkswagen (VOW.GR) pre-close

  • Politics/Macro/World News

    • UK, France boost Storm Shadow missiles, nuclear ties and discuss migration - Bloomberg, Reuters

    • UK housing market stabilizes, buyer inquiries rise - Independent, Bloomberg

    • Trump unveils new tariffs on six additional nations

    • Trump confirms 50% copper tariff effective from 1-Aug - Truth Social

    • Netherlands May Manufacturing Production +0.5% m/m vs consensus +0.4% and prior revised (1.1%) from (1.0%)

  • Top company news

    • Earnings/updates

      • DACHs:

        • GXI.GR (Gerresheimer) -- reports Q2 EPS €0.90 vs FactSet €0.81 [4 est, €0.41-1.05]; lowers FY organic revenue growth guidance

        • BARN.SW (Barry Callebaut) -- reports 9M Sales CHF10.95B vs consensus CHF10.91B; lowers FY guidance and now expects mid to high single-digit increase in EBIT vs prior guidance a double-digit increase

        • NDX1.GR (Nordex Group) -- reports Q2 order intake in the Projects segment (ex service business) 2,310 MW vs year-ago 1,271 MW

        • SZU.GR (Suedzucker) -- reports Q1 net income (€35M) vs FactSet €3.6M [1 est]

        • HPHA.GR (Heidelberg Pharma) -- reports H1 EPS (€0.27) vs year-ago (€0.19)

        • AGR.AV (Agrana Beteiligungs) -- reports Q1 net income (€7.9M) vs year-ago €16.1M

        • FIE.GR (Fielmann Group) -- reports preliminary H1 adjusted EBITDA ~ €290M vs year-ago €230.0M; reaffirms FY outlook

      • Nordics:

        • KEMIRA.FH (Kemira) -- reports preliminary Q2 revenue €693.4M vs FactSet €719.6M [6 est, €697-732M]

        • BNOR.NO (BlueNord) -- reports Q2 net income $18.6M vs FactSet $34.2M [5 est, $21-44.5M]; guides Q3 total production between 43-49 mboepd

        • QLINEA.SS (Q-linea) -- reports Q2 EPS (SEK0.02) vs year-ago (SEK0.56)

        • AKAST.NO (Akastor) -- reports H1 net income attributable from cont. ops (NOK21M) vs year-ago NOK899M

        • EPR.NO (Europris) -- reports Q2 EPS NOK1.69 vs FactSet NOK1.43 [4 est, NOK1.33-1.60]

      • Southern Europe:

        • BELA.GA (Jumbo) -- AGM update: maintained H1 sales growth rate at +8% y/y

      • UK

        • 0H9M.LN (Carasent) -- reports Q2 EPS (SEK0.08) vs year-ago (SEK0.08)

    • M&A

      • BBVA.SM (BBVA) -- Brussels to open infringement proceedings against Spain for blocking BBVA's takeover bid for Sabadell -- Expansio

      • AALB.NA (Aalberts) -- intends to acquire GVT in Southeast Asian semicon market. Financial terms were not disclosed

      • 6762.JP (TDK) -- to implement a public buyout offer at €5.56/share, followed by a mandatory squeeze-out on Tronic's Microsystems shares

      • FNOX.SS (Fortnox) -- applies for delisting from Nasdaq Stockholm in connection with acquisition by EQT X and First Kraft

      • FII.FP (Lisi) -- announces negotiations regarding sale of MEDICAL

      • AEDAS.SM (AEDAS Homes) -- Neinor Homes, S.A. announces voluntary tender offer price adjustment after dividend announced by AEDAS

      • 9Q9.GR (Azerion Group) -- announces sale of Whow Games to DoubleDown Interactive

    • Healthcare

      • TECN.SW (Tecan Group) -- CEO, Achim von Leoprechting has decided to step down, effective 1-Aug-25

      • IVA.FP (Inventiva) -- names Jason Campagna as President of R&D and Chief Medical Officer

      • FYB.GR (Formycon) -- completes patient enrollment for FYB206 Dahlia clinical pharmacokinetic; primary endpoint results expected Q1-2026

    • Other

      • TNIE.GR (tonies) -- announces Hansjörg Müller will assume role of CFO as of 1-Sep-25 as Jan Middelhoff steps down; also appoints first Chief Revenue Officer

      • HEIJM.NA (Heijmans) -- wins contract with revenue value of €194M

      • VOW.GR (Volkswagen) -- halts deliveries of ID.Buzz to the U.S. - Handelsblatt

      • INTRUM.SS (Intrum) -- announces outcome of directed rights issue of 13.5M shares to Skandinaviska Enskilda Banken AB

  • Key rating changes

    • Upgrades

      • CNE.LN (Capricorn Energy) -- to buy from add at Peel Hunt

    • Downgrades

      • JPMorgan downgrades LUMI.SS, LUN.CN

      • APAM.NA (Aperam) -- to hold from buy at Jefferies

      • RRTL.GR (RTL Group) -- to neutral from overweight at JPMorgan

      • ICAD.FP (Icade) -- to sell from neutral at Goldman Sachs

      • GEST.SM (Gestamp Automoción) -- to hold from buy at Bestinver Securities

  • Data

    • Nikkei (0.66%) to 39556.60

    • Hang Seng +0.34% to 23973.57

    • Shanghai Composite +0.57% to 3512.91

    • S&P futures (15.3) vs prior close of 6307.3

    • €-$ +0.0019 or +0.16% to 1.1741

    • $-¥ (0.09) or (0.06%) to 146.24

    • €-¥ +0.18 or +0.10% to 171.69

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE